Search results
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 6 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 1 day agoOver 100 years of market history reveals that the stocks that go on to make the biggest gains tend...
Dell Technologies' market cap exceeds $100B for the first time - Boston Business Journal
The Business Journals· 6 hours agoThe market value of Dell Technologies crossed the $100 billion threshold for the first time while...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
GuruFocus.com via Yahoo Finance· 5 days agoThe details were released through an 8-K filing. This announcement comes in the wake of a...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 1 day agoCasgevy was developed in a partnership with Vertex Pharmaceuticals, which seems to be valuable for...
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Clinical Trials Arena via Yahoo Finance· 16 hours agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...
Remembering Quant King Jim Simons
GuruFocus.com via Yahoo Finance· 2 days agoOther notable top stocks that have had a long-term, continuous presence in the equity portfolio include VeriSign Inc. (NASDAQ:VRSN) and Vertex ...
Stock Market Moves Toward Highs; Arista, Toast, Palantir Key Earnings Movers: Weekly Review
Investor's Business Daily· 5 days agoFerrari beat on the top and bottom lines for the first quarter, but the Italian sports carmaker...
Could Stem Cells One Day Cure Diabetes? - Slashdot
Slashdot· 4 days agoBrian Shelton's type 1 diabetes was treated with an infusion of insulin-producing pancreas cells (grown from stem cells). In 2021, the New York Times reported: Now his body automatically controls ...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
GuruFocus.com via Yahoo Finance· 5 days agoThis financial stability supports the company's ongoing and future R&D efforts. Strategic Collaborations and Future Directions The company continues to benefit from its strategic collaboration ...